XML 57 R40.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Equity (Details Textual) - USD ($)
1 Months Ended 12 Months Ended
Nov. 10, 2016
Mar. 08, 2016
Mar. 31, 2017
Mar. 16, 2017
Mar. 25, 2016
Nov. 19, 2015
Jul. 31, 2017
Jul. 31, 2016
Mar. 13, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Stock based compensation expense             $ 981,494 $ 10,211,507  
Stock Issued During Period, Value, Issued for Services             190,427 1,185,479  
Share-based Compensation, Total             $ 1,696,926 11,496,025  
Stock Issued During Period, Value, Stock Options Exercised         $ 30,000     $ 0  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period         15,715        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross             320,000 1,507,500  
Stockholders' Equity, Reverse Stock Split             1-for-100    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit               $ 7.25  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit               $ 10.00  
Prior Period Adjustment [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Stock based compensation expense             $ 295,645 $ 99,039  
Stock Issued During Period, Shares, New Issues             6,228    
Stockholders' Equity, Reverse Stock Split             1 : 100    
Stock Issued During Period, Shares, Reverse Stock Splits             60    
Stock Issued During Period, Shares, Conversion of Convertible Securities             6,168    
Consultants [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Stock Issued During Period, Shares, Issued for Services             2,875 42,500  
Stock Issued During Period, Value, Issued for Services             $ 22,051    
Share-based Compensation, Total               $ 388,320  
Advisor [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Class of Warrant or Right, Exercise Price of Warrants or Rights                 $ 10.00
Warrants and Rights Outstanding             229,360    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                 45,000
Board of Directors Chairman [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Stock Issued During Period, Shares, Share-based Compensation, Forfeited     680,000            
Chief Executive Officer [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Stock Issued During Period, Shares, Share-based Compensation, Forfeited     825,000            
Management [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Fair value of option granted             $ 2,464,566 $ 10,642,786  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross             320,000 1,507,500  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit             $ 9.00    
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit             10.00    
Warrant [Member] | Advisor [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share Price                 $ 8.00
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price       $ 10.00          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate       111.00%          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate       1.63%          
Warrant [Member] | Board of Directors Chairman [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Stock Issued During Period, Shares, Share-based Compensation, Forfeited     285,000            
Warrant [Member] | Chief Executive Officer [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Stock Issued During Period, Shares, Share-based Compensation, Forfeited     40,000            
Minimum [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share Price             $ 5.61 $ 7.00  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate             76.00% 124.00%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate             0.88% 0.71%  
Minimum [Member] | Consultants [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Shares Issued, Price Per Share             $ 7.52 $ 7.75  
Maximum [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share Price             $ 13.00 $ 10.00  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate             348.00% 373.00%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate             2.55% 2.05%  
Maximum [Member] | Consultants [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Shares Issued, Price Per Share             $ 7.75 $ 10.50  
Letter Of Intent [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Stock Issued During Period, Value, New Issues $ 85,102     $ 83,274   $ 120,347      
Stock Issued During Period, Shares, New Issues 14,327     25,072   14,327   74,443  
Additional Stock Issue During Period Upon Milestones           92,634      
Share-based Compensation, Total               $ 644,037  
Shares Issued, Price Per Share       $ 7.75          
Letter Of Intent [Member] | March 16, 2017 [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share-based Compensation, Total             $ 168,376    
Letter Of Intent [Member] | Eighth March Two Thousand Sixteen [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Stock Issued During Period, Value, New Issues   $ 32,775              
Stock Issued During Period, Shares, New Issues   3,582              
Share-based Compensation, Total             $ 153,122    
Letter Of Intent [Member] | Minimum [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Shares Issued, Price Per Share       5.94       $ 7.75  
Letter Of Intent [Member] | Maximum [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Shares Issued, Price Per Share       $ 7.75       $ 9.90  
Stock Option [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross             320,000 1,507,500  
Stock Option [Member] | Management [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights             These options vest as follows: (i) 100,000 shares vest on the eighteenth month from the February 6, 2017 grant date, with the remaining 100,000 shares vesting over the next eighteen months; (ii) 85,000 shares vest over thirty-six months from the date of grant; (iii) 11,667 shares vested on August 29, 2017 upon the uplisting of the Company to Nasdaq; (iv) 11,667 shares vested on December 13, 2016 upon the cumulative funding of the Company of or in excess of $5,000,000 by institutional investors starting from November 4, 2016; and (v) 11,666 shares vest upon the first submission of an NDA to the FDA for one of Companys products by Company itself or a Company licensee. These options vest as follows: (i) 1,437,500 shares vested immediately; (ii) 23,334 shares vested on August 29, 2017 upon the uplisting of the Company to Nasdaq; (iii) 23,334 shares vested on December 13, 2016 upon the cumulative funding of the Company of or in excess of $5,000,000 by institutional investors commencing May 5, 2016; and (iv) 23,332 shares vest upon the first submission of a NDA to the FDA for one of the Company’s products by either the Company or a Company licensee.  
Stock Option [Member] | Minimum [Member] | Management [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period             5 years 5 years  
Stock Option [Member] | Maximum [Member] | Management [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period             10 years 10 years  
Non Vested Stock Options [Member] | Stock Option [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Unrecognized stock-based compensation cost             $ 1,622,019    
November 12 Option Grant [Member] | Stock Option [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Vesting Period     3 years